Morgan Stanley’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
163,097
+89,436
| +121% | +$601K | ﹤0.01% | 5049 |
|
|
2025
Q1 | $666K | Sell |
73,661
-8,212
| -10% | -$74.2K | ﹤0.01% | 5198 |
|
|
2024
Q4 | $1.42M | Sell |
81,873
-11,393
| -12% | -$197K | ﹤0.01% | 4917 |
|
|
2024
Q3 | $1.49M | Buy |
93,266
+44,215
| +90% | +$707K | ﹤0.01% | 4818 |
|
|
2024
Q2 | $699K | Sell |
49,051
-58,511
| -54% | -$834K | ﹤0.01% | 5145 |
|
|
2024
Q1 | $1.52M | Buy |
107,562
+8,954
| +9% | +$127K | ﹤0.01% | 4724 |
|
|
2023
Q4 | $1.49M | Buy |
98,608
+77,662
| +371% | +$1.17M | ﹤0.01% | 5107 |
|
|
2023
Q3 | $331K | Sell |
20,946
-8,957
| -30% | -$142K | ﹤0.01% | 5342 |
|
|
2023
Q2 | $453K | Sell |
29,903
-11,865
| -28% | -$180K | ﹤0.01% | 5264 |
|
|
2023
Q1 | $606K | Buy |
41,768
+16,882
| +68% | +$245K | ﹤0.01% | 5142 |
|
|
2022
Q4 | $336K | Buy |
24,886
+14,356
| +136% | +$194K | ﹤0.01% | 5435 |
|
|
2022
Q3 | $166K | Sell |
10,530
-10,655
| -50% | -$168K | ﹤0.01% | 5818 |
|
|
2022
Q2 | $258K | Buy |
21,185
+12,824
| +153% | +$156K | ﹤0.01% | 5768 |
|
|
2022
Q1 | $78K | Buy |
8,361
+4,199
| +101% | +$39.2K | ﹤0.01% | 6470 |
|
|
2021
Q4 | $71K | Buy |
+4,162
| New | +$71K | ﹤0.01% | 6632 |
|